Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05814055
PHASE2

The Potential of Kava in Enabling Tobacco Cessation - Its Holistic Effects in Managing Stress and Insomnia Associated With Abstinence

Sponsor: University of Florida

View on ClinicalTrials.gov

Summary

This study will evaluate the compliance with a daily kava regimen among active smokers who have an intention to quit smoking. This study will also investigate whether kava use can facilitate tobacco cessation, reduce stress, and improve sleep.

Key Details

Gender

All

Age Range

21 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

76

Start Date

2024-06-06

Completion Date

2027-10-31

Last Updated

2026-01-27

Healthy Volunteers

No

Conditions

Interventions

DRUG

Placebo

Participants on this arm will take one placebo capsule orally three times daily for 4 weeks.

DRUG

AB-free kava

Participants on this arm will take one kava capsule (each capsule contains 75 mg of kavalactones) orally three times daily for 4 weeks.

Locations (1)

University of Florida

Gainesville, Florida, United States